why choose us

First received: November 08, 2023

Clinical Trial: Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

Study Status: Completed

Recruit Status: RECRUITING

Condition: SARS-CoV-2

Study Type: OBSERVATIONAL


Official Title: Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran Vaccines in the United States

Brief Summary: The main objective of the study is to evaluate the safety of the elasomeran/davesomeran and andusomeran vaccines as used in routine clinical practice.

Read more